quarta-feira, 22 de junho de 2016

Alternativa às estatinas aprovada no RU (colesterol)





http://www.express.co.uk/life-style/health/682284/cholesterol-drug-treatment-approved-NICE-NHS


Citando:



"Patients that have high levels of LDL cholesterol, an inherited form of high cholesterol levels and those who are statin intolerant will benefit.
Despite the widespread use of statins and other lipid-lowering therapies to reduce raised cholesterol levels, some people in the UK remain at significant risk of having a cardiovascular event and are unable to lower their cholesterol to levels indicated within national guidelines.
Alirocumab belongs to the most recent cholesterol-lowering class of treatments called PCSK9 inhibitors.
PCSK9 is a protein that plays an important role in managing ‘bad’ cholesterol by regulating the number of receptors for ‘bad’ cholesterol on the liver’s surface."